303 results on '"Van Veldhuisen, Dirk J"'
Search Results
2. Biomarker and transcriptomics profiles of serum selenium concentrations in patients with heart failure are associated with immunoregulatory processes
3. Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF
4. Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection Fraction
5. Sodium Thiosulfate in Acute Myocardial Infarction
6. Perirenal Adipose Tissue Is Associated With Renal Dysfunction and Abnormal Hemodynamics in Patients With Heart Failure With Preserved Ejection Fraction
7. Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction
8. The influence of body mass index on clinical interpretation of established and novel biomarkers in acute heart failure
9. PREDICTING STROKE IN HEART FAILURE AND PRESERVED EJECTION FRACTION WITHOUT ATRIAL FIBRILLATION
10. Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population
11. Galectin-3, Acute Kidney Injury and Myocardial Damage in Patients With Acute Heart Failure
12. Heart failure with normal LVEF in BIOSTAT-CHF
13. Pathophysiologic Processes and Novel Biomarkers Associated With Congestion in Heart Failure
14. Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
15. Surrogate markers of gut dysfunction are related to heart failure severity and outcome–from the BIOSTAT-CHF consortium
16. Decongestion, kidney injury and prognosis in patients with acute heart failure
17. Cardiovascular determinants of impaired placental function in women with cardiac dysfunction
18. Renal Compression in Heart Failure
19. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial
20. A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction
21. Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial
22. Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trial
23. Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction
24. Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF
25. The Additive Prognostic Value of Serial Plasma Interleukin-6 Levels over Changes in Brain Natriuretic Peptide in Patients with Acute Heart Failure
26. Relation of Decongestion and Time to Diuretics to Biomarker Changes and Outcomes in Acute Heart Failure
27. Incidence and Outcomes of Pneumonia in Patients With Heart Failure
28. Impact of Geographic Region on the COMMANDER-HF Trial
29. Preoperative cardiac screening using NT-proBNP in obese patients 50 years and older undergoing bariatric surgery: a study of 310 consecutive patients
30. Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction
31. Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II)
32. Optimal treatment of underlying conditions improves rhythm control outcome in atrial fibrillation – Data from RACE 3
33. High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men
34. Doppler gradients, valve area and ventricular function in pregnant women with aortic or pulmonary valve disease: Left versus right
35. Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial
36. Distinct Pathological Pathways in Patients With Heart Failure and Diabetes
37. Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF
38. Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure
39. Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality
40. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study
41. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction
42. Utility of Urine Neutrophil Gelatinase-Associated Lipocalin for Worsening Renal Function during Hospitalization for Acute Heart Failure: Primary Findings of the Urine N-gal Acute Kidney Injury N-gal Evaluation of Symptomatic Heart Failure Study (AKINESIS)
43. Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population
44. Agreement of 2D transthoracic echocardiography with cardiovascular magnetic resonance imaging after ST-elevation myocardial infarction
45. Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction
46. The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure BIOSTAT-CHF Subanalysis
47. A Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure: The COMMANDER HF study
48. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction
49. Biological versus mechanical heart valve prosthesis during pregnancy in women with congenital heart disease
50. Efficacy and safety of direct oral anticoagulants during pregnancy; a systematic literature review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.